We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Sysmex Presents Next-Generation Diagnostic Solutions at ADLM 2026

By LabMedica International staff writers
Posted on 28 Jul 2026

Sysmex America is participating in the ADLM 2026 Clinical Lab Expo, taking place July 28–30 in Anaheim, California. More...

At booth 2701, the company is presenting diagnostic solutions spanning hematology, hemostasis, urinalysis, flow cytometry, and laboratory informatics, with a focus on improving efficiency, diagnostic confidence, and the quality of patient results.

Leading the showcase is the next-generation XR-Series hematology portfolio, which builds on the company’s XN-Series platform with higher throughput, enhanced analytics, advanced three-dimensional scattergram technology, and integration with complementary workflow solutions. The XR-1000 processes up to 110 samples per hour and combines advanced parameters with onboard decision rules designed to standardize and simplify hematology testing.

For higher-volume laboratories, Sysmex is featuring the modular XR-9000 system, which is designed to increase throughput while minimizing manual touchpoints. The company is also presenting the DIFF-Line by CellaVision for blood-cell differential workflows and Sentinel SENTiFIT systems for high-throughput fecal occult blood and calprotectin testing. Some of these products are not available for sale in all countries.

Another highlight is the new Sysmex CentralOps Command Center, a customizable informatics solution that consolidates data from different Sysmex systems, provides real-time laboratory monitoring, and uses configurable rules to support sample processing and workflow management. The platform is intended to help laboratories identify operational insights and coordinate more efficient decision-making from a centralized interface. CentralOps is not currently available for sale.

In hemostasis, Sysmex is showcasing the new CN-9000 configuration for busy, high-volume laboratories. The system combines high throughput with continuous sample loading and automated rerun and reflex testing to streamline operations. The broader CN-Series consolidates routine and specialized testing on an automated platform, while the compact CA-600 Series is designed for lower-volume laboratories performing routine hemostasis assays.

The company’s urinalysis display includes the UN-Series, an automated platform that integrates urine chemistry, particle counting, sediment analysis, and confirmatory digital imaging. The system is designed to increase walkaway time while supporting accurate and efficient urine testing.

Sysmex is also presenting flow cytometry solutions, including the PS-10 sample preparation system and the research-use-only XF-1600 10-color flow cytometer. The XF-1600 combines fluidics and optical technologies to support high detection sensitivity at elevated sample flow rates. Visitors can additionally explore a portfolio of more than 200 single-color analyte-specific antibody reagents for flow cytometry applications.

Through live demonstrations and discussions with laboratory professionals, Sysmex is highlighting how specialty automation and connected informatics can help laboratories manage growing workloads, reduce manual intervention, and prepare for evolving diagnostic demands.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
POC Immunoassay Analyzer
Procise DX
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.